Policy debates generally return to scheduling and bans. India and America equally facial area versions of the identical dilemma: no matter whether to impose broader, class-vast controls around fentanyl analogs as well as their precursors, or to maintain compound-by-compound scheduling that will lag driving traffickers’ innovation.To put it simply